LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: MAFLD in COVID-19 patients: an insidious enemy.

    Dongiovanni, Paola / Meroni, Marica / Longo, Miriam / Fracanzani, Anna Ludovica

    Expert review of gastroenterology & hepatology

    2020  Volume 14, Issue 10, Page(s) 867–872

    Abstract: ... viral shedding time. The presence of fibrosis in MAFLD patients is another risk factor for severity of COVID-19 ... during COVID-19 and a more severe infection occurs in patients with pre-existing liver diseases ... patients had a higher risk of progression to severe COVID-19, higher abnormal liver tests and longer ...

    Abstract The pandemic Sars-CoV-2 infection represents a dramatic health challenge worldwide. Pneumonia is considered the major damage caused by the virus. However, recent data have highlighted the impact of the Sars-CoV-2 related disease namely COVID-19 on the liver. Hepatic abnormalities significantly increase during COVID-19 and a more severe infection occurs in patients with pre-existing liver diseases, among which the most frequent is metabolic-associated fatty liver disease (MAFLD). It has been described that MAFLD patients had a higher risk of progression to severe COVID-19, higher abnormal liver tests and longer viral shedding time. The presence of fibrosis in MAFLD patients is another risk factor for severity of COVID-19. Due to the overgrowing prevalence of MAFLD, it could be speculated that a large proportion of the population might be at risk of severe COVID-19 and the identification of these patients possibly by using liver enzymes as risk predictors may be crucial for an early diagnosis and for the management of the infection.
    MeSH term(s) Aged ; Betacoronavirus ; COVID-19 ; Comorbidity ; Coronavirus Infections/epidemiology ; Fatty Liver/epidemiology ; Fatty Liver/etiology ; Female ; Global Health ; Humans ; Male ; Metabolic Syndrome/complications ; Metabolic Syndrome/epidemiology ; Pandemics ; Pneumonia, Viral/epidemiology ; Prevalence ; Risk Factors ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-08-04
    Publishing country England
    Document type Editorial
    ZDB-ID 2481021-6
    ISSN 1747-4132 ; 1747-4124
    ISSN (online) 1747-4132
    ISSN 1747-4124
    DOI 10.1080/17474124.2020.1801417
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: MAFLD in COVID-19 patients: an insidious enemy

    Dongiovanni, Paola / Meroni, Marica / Longo, Miriam / Fracanzani, Anna Ludovica

    Expert Rev Gastroenterol Hepatol

    Abstract: ... viral shedding time. The presence of fibrosis in MAFLD patients is another risk factor for severity of COVID-19 ... during COVID-19 and a more severe infection occurs in patients with pre-existing liver diseases ... patients had a higher risk of progression to severe COVID-19, higher abnormal liver tests and longer ...

    Abstract The pandemic Sars-CoV-2 infection represents a dramatic health challenge worldwide. Pneumonia is considered the major damage caused by the virus. However, recent data have highlighted the impact of the Sars-CoV-2 related disease namely COVID-19 on the liver. Hepatic abnormalities significantly increase during COVID-19 and a more severe infection occurs in patients with pre-existing liver diseases, among which the most frequent is metabolic-associated fatty liver disease (MAFLD). It has been described that MAFLD patients had a higher risk of progression to severe COVID-19, higher abnormal liver tests and longer viral shedding time. The presence of fibrosis in MAFLD patients is another risk factor for severity of COVID-19. Due to the overgrowing prevalence of MAFLD, it could be speculated that a large proportion of the population might be at risk of severe COVID-19 and the identification of these patients possibly by using liver enzymes as risk predictors may be crucial for an early diagnosis and for the management of the infection.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #670232
    Database COVID19

    Kategorien

  3. Article ; Online: MAFLD in COVID-19 patients

    Dongiovanni, Paola / Meroni, Marica / Longo, Miriam / Fracanzani, Anna Ludovica

    Expert Review of Gastroenterology & Hepatology

    an insidious enemy

    2020  Volume 14, Issue 10, Page(s) 867–872

    Keywords Hepatology ; Gastroenterology ; covid19
    Language English
    Publisher Informa UK Limited
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 2481021-6
    ISSN 1747-4132 ; 1747-4124
    ISSN (online) 1747-4132
    ISSN 1747-4124
    DOI 10.1080/17474124.2020.1801417
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top